Autolus Therapeutics (AUTL) Earnings Date & Reports

Industry: @Biotechnology

A.I. Advisor

published Earnings

AUTL is expected to report earnings to fall 5.86% to -20 cents per share on October 31

Autolus Therapeutics AUTL Stock Earnings Reports

Q3'24

Est.

$-0.21

Q2'24

Missed

by $0.03

Q1'24

Missed

by $0.16

Q4'23

Est.

$-0.44

Q3'23

Missed

by $0.01

The last earnings report on August 08 showed earnings per share of -21 cents, missing the estimate of -19 cents. With 1.18M shares outstanding, the current market capitalization sits at 1.18B.

View a ticker or compare two or three

Compare

AUTL

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For AUTL
(Try 14 days for $1 only)

Ad is loading...

A.I.Advisor

published price charts

View to see Real Time Patterns for AUTL (Try 14 days for $1 only)

A.I. Advisor

published General Information

General Information

a developer of cancer treatments

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Biotechnology

Address

191 Wood Lane

Phone

+44 2038296230

Employees

471

Web

https://www.autolus.com